Outcomes Study for Coronavirus
(CANCOV Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on understanding the outcomes of COVID-19 survivors and their caregivers over time. It explores what happens to individuals who had COVID-19, whether they experienced mild symptoms or required hospitalization, and examines their recovery in both the short and long term. The study also investigates important factors like genetics and immunity to determine what influences recovery. Individuals who tested positive for COVID-19 or had symptoms and were exposed to the virus may be suitable candidates for this study. Family caregivers of hospitalized COVID-19 patients are included if they are involved in the patient’s care. As an unphased trial, this study offers participants the opportunity to contribute to a deeper understanding of COVID-19 recovery and its long-term effects.
Why are researchers excited about this trial?
The Canadian COVID-19 Prospective Cohort Study is interesting because it's not focusing on a specific treatment but rather on understanding the long-term effects and outcomes of COVID-19 on individuals. Researchers are excited about this trial because it aims to gather comprehensive data on how COVID-19 impacts people over time, which can inform future treatment strategies and public health policies. Unlike typical studies that test new drugs or vaccines, this study provides valuable insights into the progression of the disease and its lasting effects, helping to identify potential gaps in current healthcare approaches. By focusing on a wide range of health outcomes, this study has the potential to improve our understanding of COVID-19 and guide more effective interventions and support systems.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are monitored for short-term outcomes during hospitalization or isolation at home
Follow-up
Participants are monitored for safety and effectiveness after treatment
Long-term Follow-up
Optional extension for monitoring long-term outcomes related to Long-COVID
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
University Health Network, Toronto
Lead Sponsor
Unity Health
Collaborator
The Hospital for Sick Children
Collaborator
University of Toronto
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Canadian Frailty Network
Collaborator